Editor's Note: the "Trending USA Stocks" column tracks the day's top bullish stocks in the USA market, aiding investors in promptly identifying opportunities for potential gains.

05/11/2025 Eastern Time in USA The Dow Jones Industrial Average rose by 0.48%, closing at 47311.0 points; the Nasdaq Composite rose by 0.65%, closing at 23499.8 points; the S&P 500 Index rose by 0.37%, closing at 6796.29 points. 

Sahm has compiled the Top 10 Daily Stock Price Gainers in the USA market.

Solid Power, Inc. - Class A Common Stock: Overnight gain 51.6%, Strategic partnerships and analyst optimism boost solid-state battery maker's market position

Solid Power, Inc. (NASDAQ: SLDP), a leading developer of all-solid-state battery technology, is making significant strides in the advancement of next-generation energy storage solutions. The company's core focus lies in the development and commercialization of all-solid-state batteries, leveraging its proprietary sulfide-based solid electrolyte technology to replace traditional liquid or gel polymer electrolytes found in conventional lithium-ion batteries. This innovative approach aims to enhance battery performance and safety, potentially catalyzing major breakthroughs in key sectors such as electric vehicles and renewable energy storage. Solid Power's cutting-edge technology is poised to play a crucial role in driving the progression of the new energy industry. The company's advancements in solid-state battery technology could potentially address critical challenges in the energy storage market, including improved energy density, faster charging capabilities, and enhanced safety profiles. As the global push for sustainable energy solutions intensifies, Solid Power's contributions to the field position it as a key player in shaping the future of energy storage and utilization. Investors and industry observers are closely monitoring Solid Power's progress, as successful commercialization of its technology could have far-reaching implications for various sectors reliant on advanced energy storage solutions.

Solid Power, Inc. - Class A Common Stock (SLDP) experienced a significant surge in stock price, driven by multiple factors. The company's strategic partnerships with Samsung SDI and BMW, particularly the joint evaluation agreement with Samsung SDI, demonstrate market validation of its technology. Additionally, Needham analyst Chris Pierce maintained a "Buy" rating and raised the price target, reflecting institutional confidence in the company's prospects. SLDP's leading position in solid-state battery technology, coupled with the rapid growth of the electric vehicle industry, provided strong support for the stock. These factors collectively propelled SLDP's shares to soar 51.6% in a single day, bringing its year-to-date gains to an impressive 350.3%. The company's advancements in the burgeoning EV battery market continue to attract investor attention and drive market optimism.

Entravision Communications Corporation Class A: Overnight gain 43.9%, Digital advertising growth and diversified business model boost investor confidence in media company.

Entravision Communications Corporation, a Delaware-incorporated entity founded in January 1996, has established itself as a global leader in advertising solutions, media, and technology. The company offers comprehensive end-to-end advertising solutions across a diverse range of multimedia platforms, encompassing digital, television, and audio assets. In accordance with financial reporting requirements, Entravision has strategically segmented its operations into three distinct divisions: Digital, Television, and Audio. This organizational structure enables the company to efficiently manage and report on its diversified portfolio of advertising mediums, thereby delivering a full spectrum of advertising services to its clientele. As a prominent player in the media and advertising landscape, Entravision leverages its multi-platform approach to provide advertisers with integrated solutions that maximize reach and engagement across various consumer touchpoints. The company's strategic positioning in these key sectors underscores its commitment to adapting to the evolving media consumption habits and advertising trends in the global marketplace.

Notably, the surge in Entravision Communications Corporation Class A (EVC) stock price can be attributed to multiple factors. As a global leader in advertising solutions, media, and technology, EVC's diversified business structure demonstrates competitive advantages in the current market environment. The company's foray into digital advertising has benefited from the rapid growth in this sector. EVC's stock soared 43.9% overnight, bringing its year-to-date gain to 29.5%, with this robust market performance attracting investor attention. Furthermore, the company's relatively modest market capitalization of $259 million makes its stock price more sensitive to positive news. These factors have collectively driven the significant rise in EVC's share value, highlighting the company's potential in the evolving media landscape.

NEUROPACE, INC.: Overnight gain 38.1%, Stock surges on strong Q3 results and raised sales guidance, boosting investor confidence

NeuroPace, Inc. (NASDAQ: NPCE), a pioneering medical device company incorporated in Delaware on November 19, 1997, is at the forefront of developing innovative neuromodulation technologies aimed at enhancing the quality of life for individuals suffering from epilepsy. The firm's core business is centered on the research, development, and manufacture of cutting-edge medical devices designed to effectively reduce or eliminate epileptic seizures. The company's advanced technological solutions not only offer patients improved treatment options but also contribute significantly to the advancement of neuroscience. By leveraging its expertise in neuromodulation, NeuroPace, Inc. has positioned itself as a key player in the rapidly evolving field of neurological interventions. As the medical device sector continues to expand, NeuroPace, Inc.'s focus on addressing the unmet needs of epilepsy patients through innovative therapies underscores its commitment to both scientific progress and improving patient outcomes. The company's continued investment in research and development is expected to drive future growth and potentially unlock new applications for its proprietary technology platform.

NEUROPACE, INC. (NPCE) saw a significant surge in its stock price following its impressive third-quarter financial results and optimistic sales outlook. The company reported a narrower-than-expected loss of $0.11 per share, marking a 42.11% year-over-year improvement. Revenue climbed 29.89% to $27.35 million, surpassing market expectations. Furthermore, NEUROPACE raised its fiscal 2025 sales guidance to $97-$98 million, exceeding analyst projections. These positive developments bolstered investor confidence, propelling NPCE shares to soar 38.1% on the news, bringing its year-to-date gains to 16.0%. The company's strong performance and upbeat forecast underscore its potential for continued growth in the medical device sector.

Lemonade: Overnight gain 34.2%, Strong Q3 results and raised guidance boost investor confidence, driving stock surge

Lemonade, Inc. (NYSE: LMND), a disruptive force in the insurance sector since its inception in 2015, is pioneering the digital transformation of the industry through innovative business models. The company leverages a potent combination of cutting-edge technology, data analytics, artificial intelligence, contemporary design principles, and behavioral economics to revolutionize insurance offerings. The firm's mission is twofold: to deliver more attractive, cost-effective, and precisely tailored insurance products while simultaneously amplifying its social impact. Lemonade has successfully established a vertically integrated operational framework across the United States and Europe, encompassing wholly-owned insurance subsidiaries complemented by proprietary technological infrastructure. This strategic approach positions Lemonade at the forefront of the insurtech revolution, challenging traditional industry paradigms and setting new benchmarks for customer engagement and operational efficiency in the digital age.

Lemonade (LMND) shares surged following the company's impressive third-quarter financial results, which exceeded market expectations. The insurtech firm reported a narrower loss per share of $0.51, outperforming analyst estimates of $0.73 and marking a 46.32% year-over-year improvement. Revenue reached $194.5 million, up 42.39% from the previous year and surpassing forecasts by 5.41%. Lemonade raised its fiscal 2025 revenue guidance to $727-$732 million, above analyst projections. The company's fourth-quarter sales outlook also topped market estimates. These positive factors drove Lemonade's stock price up 34.2% on the day, bringing its year-to-date gain to 114.6%. The robust performance reflects investor confidence in the company's improving financials and future growth prospects.

Rigel Pharmaceuticals, Inc.: Overnight gain 33.4%, Strong financials and raised guidance boost investor confidence, driving stock surge

Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) is a biotechnology firm specializing in the development of innovative therapies for hematological disorders and oncology. The company's portfolio is anchored by two key products: TAVALISSE® (fostamatinib disodium hexahydrate) tablets and REZLIDHIA™ (olutasidenib) capsules. TAVALISSE, the company's flagship product, is a first-in-class oral spleen tyrosine kinase (SYK) inhibitor approved for the treatment of chronic immune thrombocytopenia (ITP). This groundbreaking medication represents a significant advancement in the management of this challenging hematological condition. Complementing its hematology focus, Rigel has expanded into the oncology space with REZLIDHIA, a targeted therapy for relapsed or refractory acute myeloid leukemia (AML) patients harboring a susceptible IDH1 mutation. This strategic move underscores the company's commitment to addressing unmet medical needs in challenging-to-treat cancers. Rigel Pharmaceuticals continues to leverage its expertise in small molecule drug development to advance its pipeline, aiming to improve patient outcomes and quality of life across various hematological and oncological indications. The company's dedication to innovation positions it as a notable player in the biotechnology sector, with potential for future growth and expansion of its therapeutic offerings.

Rigel Pharmaceuticals, Inc. (RIGL) has seen a significant surge in its stock price, driven by the company's exceptional performance and surpassing market expectations across multiple metrics. The third-quarter financial report revealed earnings per share of $1.46, marking a 108.57% year-over-year increase and substantially exceeding analyst projections of $0.84. Sales reached $69.462 million, up 25.59% year-over-year, also surpassing expectations. Rigel raised its fiscal 2025 sales guidance to $285-$290 million, above analyst forecasts, reflecting management's confidence in future growth. The company outperformed its peers with a revenue growth rate of 176.01% and a net profit margin of 58.63%, both surpassing industry averages. Strong financial performance and positive analyst ratings have bolstered investor confidence, propelling the stock's significant upward momentum.

Teradata Corporation: Overnight gain 32.6%, Shares surge on strong earnings, raised guidance, and positive outlook, boosting investor confidence.

Teradata Corporation (NYSE: TDC), a global leader in analytics data solutions, specializes in integrated data warehousing, big data analytics, and business applications. The company offers comprehensive data warehouse solutions, encompassing both hardware and software components, as well as related consulting and support services. Renowned for its advanced analytics technology, Teradata enables organizations to consolidate diverse data sets into a unified, integrated data warehouse. This integration facilitates the transformation of raw data into actionable insights, empowering clients to make informed, data-driven decisions. Teradata's proprietary solutions allow businesses to leverage their data assets more effectively, driving operational efficiency and strategic growth. The company's robust platform supports a wide range of industries, including finance, healthcare, retail, and telecommunications. With a strong track record of market performance, Teradata has garnered high regard among industry analysts and maintains a loyal customer base. The company's continued innovation in cloud-based analytics and artificial intelligence positions it favorably in the rapidly evolving data management landscape. As organizations increasingly prioritize data-driven decision-making, Teradata's comprehensive suite of analytics solutions continues to attract enterprise-level clients seeking to harness the full potential of their data resources.

Teradata Corporation (TDC) shares surged 32.6% following the release of its better-than-expected Q3 financial results and optimistic future outlook. The data analytics firm reported earnings per share of $0.72, significantly surpassing analysts' expectations of $0.54. Quarterly revenue reached $416 million, exceeding the projected $406 million. Teradata also raised its fiscal 2025 guidance, with GAAP EPS now forecast at $1.22-$1.26, up from $1.04-$1.12, and adjusted EPS projected at $2.38-$2.42, increased from $2.17-$2.25. Both ranges surpass analyst estimates. Furthermore, the company anticipates Q4 performance to outperform market expectations. These positive signals substantially boosted investor confidence, driving Teradata's stock price higher and notably reducing its year-to-date decline. The robust financial performance and upward revision of future projections underscore Teradata's strengthening market position in the data analytics sector.

Kennedy-Wilson Holdings, Inc.: Overnight gain 31.2%, Acquisition proposal from CEO and Fairfax Financial boosts stock, reflecting positive market sentiment

Kennedy-Wilson Holdings, Inc. (NYSE: KW), established in 1977, is a global real estate investment and services firm. Operating as a holding company, it conducts its primary operations through its wholly-owned subsidiary, Kennedy Wilson. The company's business model is structured around two core segments: 1. KW Investment: This division focuses on co-investing with strategic partners in a diverse portfolio of real estate assets, including multifamily properties, commercial real estate, office buildings, and residential mortgage loans. 2. KW Services: This segment offers comprehensive real estate-related services to investors and lenders, with a particular emphasis on serving financial institutions. Kennedy-Wilson's investment strategy leverages its extensive industry expertise and global network to identify and capitalize on value-add opportunities across various real estate sectors. The company's service offerings encompass a wide range of real estate solutions, including property management, asset management, and advisory services. With its dual-pronged approach, Kennedy-Wilson Holdings, Inc. has positioned itself as a prominent player in the international real estate market, adept at navigating both investment opportunities and service provision in the dynamic property sector.

Kennedy-Wilson Holdings, Inc. (KW) experienced a significant stock price surge following a buyout proposal. CEO William McMorrow and Fairfax Financial have offered to acquire the company for $10.25 per share in cash, sparking enthusiastic investor response. Consequently, KW shares skyrocketed 31.2% overnight, substantially outpacing its year-to-date gain of 1.8%. This dramatic increase reflects the market's positive outlook on the potential acquisition and a reevaluation of the company's worth. As an international real estate investment and services firm, KW's diversified business structure enhances its appeal to potential acquirers. The buyout offer has reignited interest in the company, highlighting its perceived value in the current market landscape.

SolarEdge Technologies, Inc.: Overnight gain 28.9%, Strategic partnership with Infineon boosts stock on data center infrastructure innovation prospects.

SolarEdge Technologies, Inc. (NASDAQ: SEDG), a global leader in smart energy technology, was founded in 2006 with a focus on developing innovative inverter solutions to optimize solar photovoltaic (PV) power harvesting and management. The company's pioneering DC-optimized inverter system maximizes power generation at the module level while lowering the cost of energy produced and providing advanced safety features. SolarEdge's comprehensive product portfolio includes power optimizers, inverters, and a cloud-based monitoring platform, catering to residential, commercial, and small utility-scale solar installations. Since commencing commercial operations in 2010, the company has successfully deployed approximately 34 gigawatts of its DC-optimized inverter systems across 96 countries, solidifying its position as a key player in the global solar energy market. The firm's technology addresses critical challenges in the solar industry, including module mismatch and partial shading, thereby enhancing overall system performance and reliability. SolarEdge's solutions have gained widespread adoption due to their ability to increase energy output, simplify design and installation, and improve system safety. As the solar energy sector continues to expand globally, SolarEdge Technologies remains at the forefront of innovation, driving the transition towards more efficient and cost-effective renewable energy solutions.

SolarEdge Technologies, Inc. (SEDG) shares surged 28.9% following the announcement of a strategic partnership with Infineon Technologies. The collaboration aims to develop DC power infrastructure for AI and hyperscale data centers, leveraging solid-state transformer technology to achieve conversion efficiencies exceeding 99%. This initiative is expected to significantly reduce energy consumption and carbon emissions in data centers. The partnership not only showcases SolarEdge's technological innovation but also marks its entry into the rapidly growing data center market, expanding its business scope. Investors responded positively to the company's growth prospects, driving the stock price up 201.6% year-to-date. This strategic move positions SolarEdge to capitalize on the increasing demand for efficient power solutions in the burgeoning AI and data center sectors, potentially opening new revenue streams for the company.

Babcock & Wilcox Enterprises Inc: Overnight gain 28.3%, Major contract, asset sale, and improved financials boost investor confidence, driving stock surge.

Babcock & Wilcox Enterprises, Inc. (NYSE: BW) is a global leader in renewable energy, environmental solutions, and thermal technologies. The company operates through three distinct segments: B&W Renewable, B&W Environmental, and B&W Thermal. The B&W Renewable segment focuses on cutting-edge, eco-friendly power generation technologies. B&W Environmental specializes in emissions control and environmental technology solutions, while B&W Thermal provides steam generation equipment and related services. B&W caters to a diverse clientele across industrial, power generation, and municipal sectors, offering a comprehensive portfolio of energy and emissions control solutions. The company's expertise spans various domains, including waste-to-energy, solar power, biomass energy, emissions control systems, and plant maintenance services. With its innovative technologies and solutions, Babcock & Wilcox Enterprises, Inc. is well-positioned to address the growing global demand for sustainable energy production and environmental stewardship across multiple industries.

Babcock & Wilcox Enterprises Inc (BW) has experienced a significant stock price surge due to multiple factors. The company secured a major contract worth over $1.5 billion with Applied Digital to provide 1 gigawatt of power for AI data centers, substantially boosting its order backlog and future revenue streams. Additionally, BW optimized its asset structure by divesting the Allen-Sherman-Hoff business for $29 million. The third-quarter financial report revealed improved operational performance, with revenue reaching $149 million and operating income soaring 306% year-over-year. Furthermore, BW is actively managing its debt, planning to redeem bonds due in 2026, potentially enhancing its financial position. These combined factors have bolstered investor confidence, driving BW's stock price up by 28.3%, with a year-to-date gain of 192.7%.

Veracyte Inc: Overnight gain 27.5%, Innovative research, strong financials, and analyst upgrade boost investor confidence

Veracyte Inc., established in 2006, is a pioneering molecular diagnostics company specializing in genomic solutions for early and accurate disease detection. The company's mission is to improve patient outcomes while reducing healthcare costs, particularly for conditions that often require invasive procedures for diagnosis. The firm's flagship product, the Afirma Thyroid FNA Analysis, leverages its proprietary Gene Expression Classifier (GEC) technology. This innovative diagnostic tool utilizes 142 unique gene markers to assist physicians in minimizing unnecessary surgical interventions for thyroid nodule patients. Headquartered in South San Francisco, California, with additional operations in Austin, Texas, Veracyte operates as a single business segment. The company's focus on developing cutting-edge molecular cytology diagnostics positions it at the forefront of personalized medicine and targeted healthcare solutions. Veracyte's commitment to innovation in genomic testing continues to drive its growth in the competitive biotechnology sector, as it aims to expand its portfolio of diagnostic products and services across various medical specialties.

Veracyte Inc (VCYT) experienced a significant stock price surge due to multiple factors. The company unveiled two crucial research findings, demonstrating the potential of its Afirma Genomic Sequencing Classifier in thyroid nodule evaluation, showcasing its technological prowess. Additionally, Veracyte reported better-than-expected Q3 financial results and raised its FY2025 sales guidance to $506-$510 million, surpassing analyst projections and indicating strong business growth prospects. Furthermore, Needham analysts maintained a "Buy" rating and increased the price target to $44, bolstering investor confidence. These positive catalysts collectively propelled Veracyte's stock price to soar 27.5%, bringing its year-to-date gain to 16.3%. The company's innovative approach and robust financial performance continue to attract investor attention in the precision diagnostics sector.

The Top 10 Daily Gainers in the USA market are listed as follows:

Editor's note: This content was generated by Sahm's in-house AI-enabled SaaS tool and was reviewed by our editing team.